Below are the earnings highlights for Myriad Genetics Inc. (MYGN):
-Earnings: $29.4 Mln in Q4 vs. $37.2 Mln in the same period last year.
-EPS: $0.41 in Q4 vs. $0.48 in the same period last year.
-Revenue: $189.9 Mln in Q4 vs. $188.8 Mln in the same period last year.
For comments and feedback contact: editorial@rttnews.com